TrialInternational immunopharmacology2021

Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study).

Mili Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.